No abstract available
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Benzenesulfonates / therapeutic use*
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / secondary*
-
Humans
-
Kidney Neoplasms / pathology*
-
Male
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Protein Kinase Inhibitors / therapeutic use
-
Pyridines / therapeutic use*
-
Sorafenib
-
Thyroid Neoplasms / drug therapy*
-
Thyroid Neoplasms / secondary*
-
Time Factors
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antineoplastic Agents
-
Benzenesulfonates
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Pyridines
-
Niacinamide
-
Sorafenib